UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Immune checkpoint therapy in colorectal cancer: is first better than last?

Annals of coloproctology, 2023-10, Vol.39 (5), p.439-441

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice

Journal of clinical oncology, 2008-09, Vol.26 (27), p.4516-4517

2008

Link zum Volltext

Verfügbarkeit prüfen

Quality of pathology reporting impacts on lymph node yield in colon cancer

Journal of clinical oncology, 2007-02, Vol.25 (4), p.463; author reply 463-463

2007

Link zum Volltext

Verfügbarkeit prüfen

Re: Residual Treatment Disparities After Oncology Referral for Rectal Cancer

JNCI : Journal of the National Cancer Institute, 2008-12, Vol.100 (23), p.1739-1739

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of prior exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Breast cancer research and treatment, 2020-11, Vol.184 (1), p.87

2020

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint therapy in colorectal cancer: is first better than last?

Annals of coloproctology, 2023-10, p.439-441

2023

Link zum Volltext

Verfügbarkeit prüfen

Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency

Asia-Pacific journal of clinical oncology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Breast cancer research and treatment, 2023-02, Vol.198 (1), p.67-74

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS6-35-PS6-35

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Breast cancer research and treatment, 2020-11, Vol.184 (1), p.87-95

2020

Link zum Volltext

Verfügbarkeit prüfen

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1038-1038

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study

Clinical breast cancer, 2022-10, Vol.22 (7), p.e764-e772

2022

Link zum Volltext

Verfügbarkeit prüfen

Uptake of bone‐modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry

Internal medicine journal, 2022-10, Vol.52 (10), p.1707-1716

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-18-13: Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-18-13

2020

Link zum Volltext

Verfügbarkeit prüfen

Use and impact of perioperative chemotherapy in patients with resectable colorectal cancer metastases

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.159-159

2020

Link zum Volltext

Verfügbarkeit prüfen

Syndrome of inappropriate anti‐diuretic hormone secretion secondary to carboplatin after docetaxel‐carboplatin‐trastuzumab combination for early stage HER‐2 positive breast cancer

Asia-Pacific journal of clinical oncology, 2012-09, Vol.8 (3), p.e9-e11

2012

Link zum Volltext

Verfügbarkeit prüfen

Response to “Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting”

The oncologist (Dayton, Ohio), 2009-01, Vol.14 (1), p.104-105

2009

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

Acta oncologica, 2011-06, Vol.50 (5), p.727-728

2011

Link zum Volltext

Verfügbarkeit prüfen

REVIEW ARTICLE: Cancer treatment-induced bone loss: A review

Asia-Pacific journal of clinical oncology, 2006-12, Vol.2 (4), p.156-166

2006

Link zum Volltext

Verfügbarkeit prüfen

Cancer treatment-induced bone loss: A review

Asia-Pacific journal of clinical oncology, 2006-12, Vol.2 (4), p.156-166

2006

Link zum Volltext

Verfügbarkeit prüfen

Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer

Asia-Pacific Journal of Clinical Oncology, 2012, Vol.8 (3), p.e9-e11

2012

Link zum Volltext

Verfügbarkeit prüfen

Medical authority and princely patronage: The Academia naturae curiosorum, 1652-1693

Barnett, Frances Mason

1995

Link zum Volltext
ProQuest

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

Acta oncologica (Stockholm, Sweden), 2011, Vol.50 (5), p.727-728

2011

Link zum Volltext

Verfügbarkeit prüfen

THE EXANTLATION OF TRUTH: WAYS OF KNOWING IN THE WORKS OF SIR THOMAS BROWNE

BARNETT, FRANCES JANE

1980

Link zum Volltext
ProQuest

CONSUMER DECISION-MAKING BEHAVIOR IN PURCHASING TEXTILES FOR THE HOME

BUCHANAN, FRANCES BARNETT

1970

Link zum Volltext
ProQuest

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(88)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immune checkpoint therapy in colorectal cancer: is first better than last?

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice

Quality of pathology reporting impacts on lymph node yield in colon cancer

Re: Residual Treatment Disparities After Oncology Referral for Rectal Cancer

Impact of prior exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Immune checkpoint therapy in colorectal cancer: is first better than last?

Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Abstract PS6-35: Real world outcomes in elderly women with HER2 positive advanced breast cancer

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer

Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study

Uptake of bone‐modifying agents in patients with HER2+ metastatic breast cancer with bone metastases – prospective data from a multi‐site Australian registry

Abstract P1-18-13: Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer

Use and impact of perioperative chemotherapy in patients with resectable colorectal cancer metastases

Syndrome of inappropriate anti‐diuretic hormone secretion secondary to carboplatin after docetaxel‐carboplatin‐trastuzumab combination for early stage HER‐2 positive breast cancer

Response to “Disparities in the Use of Chemotherapy and Monoclonal Antibody Therapy for Elderly Advanced Colorectal Cancer Patients in the Community Oncology Setting”

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

REVIEW ARTICLE: Cancer treatment-induced bone loss: A review

Cancer treatment-induced bone loss: A review

Syndrome of inappropriate anti-diuretic hormone secretion secondary to carboplatin after docetaxel-carboplatin-trastuzumab combination for early stage HER-2 positive breast cancer

Medical authority and princely patronage: The Academia naturae curiosorum, 1652-1693

Inflammatory breast cancer and secondary Pure Red Cell Aplasia

THE EXANTLATION OF TRUTH: WAYS OF KNOWING IN THE WORKS OF SIR THOMAS BROWNE

CONSUMER DECISION-MAKING BEHAVIOR IN PURCHASING TEXTILES FOR THE HOME

Suchergebnisse filtern